NEU neuren pharmaceuticals limited

NEU chart, page-311

  1. 370 Posts.
    lightbulb Created with Sketch. 46
    Thanks so much Crem.. if I could indulge you/another expert with one more follow up question. I believe the patent for Trof in the US/Europe expires in Jan 2032. I assume after that, Trof would be competed with and the price/royalties would reduce significantly? Accordingly the large cashflows are highly finite to the patent/exclusivity period hence the 10x multiple is applied. Is such analysis incorrect, or can you elaborate on why the 25x is more appropriate given the finite earnings window ahead? Or have I got this all wrong?!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.76
Change
0.170(1.17%)
Mkt cap ! $1.837B
Open High Low Value Volume
$14.36 $14.86 $14.25 $3.707M 254.0K

Buyers (Bids)

No. Vol. Price($)
1 2500 $14.70
 

Sellers (Offers)

Price($) Vol. No.
$14.80 1000 1
View Market Depth
Last trade - 16.10pm 16/07/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.